Study Group: Physicians who Treat Schizophrenia (US)
Council Members in this Study Group: 364
This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.
Contact Gerson Lehrman Group to survey or consult with members of this Study Group
Leading institutions connect with members of this Study Group through GLG
Leading Experts in this Study Group
- David Rosenberg
Chief of Psychiatry and Psychology
CHILDREN'S HOSPITAL OF MICHIGAN
David Rosenberg, MD, is a tenured professor and Miriam L Hamburger Endowed Chair of Psychiatry at Wayne State University and the Children's Hospital of Michigan. He is a board certified general and adult psychiatrist and pediatric psychiatrist. Dr. Rosenberg...
John Litton Jr.Chief Executive Officer and President
Litton Family Medicine, PCJ. Scott Litton, Jr., MD, FAAFP, is the Chief Executive Officer and President of Litton Family Medicine, PC in Pennington Gap, VA. He provides inpatient services and also serves as the Medical Director of the Center for Wound Care at Lee Regional Medical...
- Robert Schulte
Psychiatrist
North Scottsdale Psychiatric SpecialistsRobert Schulte, MD, is a Private Practitioner and a Psychiatrist at North Scottsdale Psychiatric Specialists in Arizona. He is board certified in Adult Psychiatry and Child and Adolescent Psychiatry with extensive experience with children and adult's...
Amit VijapuraOwner
AMIT VIJAPURA MDAmit Vijapura, MD, is a Private Practitioner in Psychiatry based in Florida. He has over 15 years of experience in the field and has expertise in depression, bipolar disorder, anxiety disorder, attention deficient disorder, and schizophrenia. Dr. Vijapura...
- Rami Kaminski
Founder and Director
Institute for Integrative PsychiatryRami Kaminski, MD, is Director and Founder of the Institute for Integrative Psychiatry in New York, a not-for-profit organization aimed at evaluating current psychiatric services and how they integrate with medicine, such as the mutual effects between...
GLG NewsSM Analyses by this Study Group's Leading Experts(?)
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
-
Neuronal nicotinic receptor agonists potential breakthrough for ADHD research
May 12, 2008
Abbott Scientists Present A New Approach for Treating Attention-Deficit Hyperactivity Disorder | biz.yahoo.com
1. Effective treatment for ADHD 2. Well tolerated with few side effects 3. Help with smoking, a big problem in ADHD patients important 4. Advantage in not being Schedule II may be helpful
-
Important New Data for Children and Adolescents
May 12, 2008
FDA Approves Strattera® for Maintenance of ADHD in Children and Adolescents | newsroom.lilly.com
1. Important new finding given safety concerns raised about this and other treatmetns 2. Nice to have data back up what has long been done clinically 3. Stimulants still first line and lack of active comparator trial
-
Exciting new treatment for OCD and Social Anxiety Disorder
March 7, 2008
FDA Approves Luvox CR (Fluvoxamine Maleate) Extended-Release Capsules for the Treatment of Social Anxiety Disorder and Obsessive Compulsive Disorder | pharmalive.com
1. Controlled release preparations are often better tolerated with fewer side effects than immediate release preparations 2. OCD and SAD are severe, highly prevalent and chronically disabling conditions 3. Despite presence of SSRIs and other treatment, e.g, cognitive behavioral therapy, up to 1/3 of patients with OCD or SAD do not respond to currently available treatments and among responders many do so only partially
-
FDA Approval of Abilify for Pediatric Bipolar disorder is a Major Advance
March 7, 2008
1. Despite common use of multiple psychotropic medications for bipolar disorder in youth, there are few FDA-approved treatments 2. Abilify is one of the safest and best tolerated of the atypical antipsychotics with fewer side effects than some of the other atypical antipsychotic medications 3. This treatment offers new hope to many children and their families
-
More questions raised than answers
February 5, 2008
Chantix And Suicide: The Latest Numbers | www.pharmalot.com
No good data that Chantix is associated with suicide Need more controlled research to answer questions Scary adverse events are not the same as side effects directly linked to medication
Members in this Study Group include these company types:
- Academic Medical Center/Hospital or Clinic
- Office Based Private Practice or Clinic
- Non-Academic Community Hospital or Clinic
- Government/Military Hospital or Clinic
- Academic Institution*
- Consultancy, Healthcare-Focused
Members in this Study Group often have these job titles:
- Physician - Attending Physician
- Owner
- Physician - Director
- Director
- President
- Medical Director
- Physician - Division Head
Related Study Groups
| Study Group Name | No. Members |
|---|---|
| Psychiatrists (US) | 1136 |
| Psychiatrists | 1535 |
| Physicians who Treat ADHD (US) | 453 |
| Physicians who Treat Depression (US) | 448 |
| Seroquel Prescribers forSchizophrenia (US) | 105 |
| Effexor XR Prescribers (US) | 144 |
| SSRI Prescribers (US) | 279 |
| Physicians who Treat Insomnia (US) | 546 |